BRC Inc. 8-K

What Happened
BRC Inc. (BRCC) announced in an 8-K that it received a notice from the New York Stock Exchange on February 11, 2026, saying the company is not in compliance with Section 802.01C because the average closing price of its Class A Common Stock was below $1.00 over a consecutive 30 trading-day period. The notice does not immediately delist the stock; the shares remain listed and tradable while the company has a chance to cure the deficiency.

Key Details

• Notice received: February 11, 2026 (NYSE cited Section 802.01C minimum $1.00 average closing price over 30 trading days).
• Cure period: Six months from receipt of the Notice to regain compliance.
• Conditions to regain compliance: On the last trading day of any calendar month during the cure period, the Common Stock must have (i) a closing price of at least $1.00 and (ii) a 30-trading-day average closing price of at least $1.00.
• Company actions: BRC intends to notify the NYSE within 10 business days that it plans to cure the deficiency and is evaluating alternatives; a press release was issued on February 13, 2026 (filed as Exhibit 99.1).

Why It Matters
This filing is material to investors because failure to regain the minimum share price could lead to delisting from the NYSE, which can reduce liquidity, limit investor access, and potentially affect the stock’s valuation. For now, trading continues and the company states the notice does not affect its business operations, financial condition, or SEC reporting obligations. Retail investors should monitor the company’s updates on steps to restore compliance and monthly share-price performance during the six-month cure period.